arrow_back Civic Audit
Share share

Fighting Synthetic Drugs: Strengthening International Cooperation

This act aims to strengthen U.S. efforts in combating international trafficking of synthetic drugs like fentanyl. It means increased support for foreign agencies, knowledge exchange, and better data collection, which should help reduce the availability of these substances and improve public safety in the U.S.
Key points
Increased financial and training support for foreign agencies combating the production and trafficking of synthetic drugs.
Exchange of knowledge and experience between U.S. and international experts to reduce demand for illicit substances.
Improved data collection on drug use and sources to more effectively combat trafficking.
Expansion of the definition of countries under surveillance due to drug production and transit, including new psychoactive substances.
article Official text account_balance Process page notifications_active Track this Bill
Status: Expired
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_2538
Sponsor: Rep. Trone, David J. [D-MD-6]
Process start date: 2021-04-14
System Note: Lustra is free, open-source civic infrastructure. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

FENTANYL Results Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2538.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-04-14.

What are the main provisions?

Key points include:

  • Increased financial and training support for foreign agencies combating the production and trafficking of synthetic drugs.
  • Exchange of knowledge and experience between U.S. and international experts to reduce demand for illicit substances.
  • Improved data collection on drug use and sources to more effectively combat trafficking.
  • Expansion of the definition of countries under surveillance due to drug production and transit, including new psychoactive substances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Trone, David J. [D-MD-6].

What is the latest detailed status?

The latest detailed status is: Ordered to be Reported by Voice Vote.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Security